optomap is the ONLY UWF technology proven to improve practice flow
Learn More
optomap imaging helps doctors find more pathology
Learm More
optomap imaging is proven to improve treatment decisions
optomap imaging enables detailed examination with no face-to-face interaction
Enter the Virtual Product Showroom to explore optomap imaging options
optomap® Recognizing Pathology
2,500 clinical and peer-reviewed studies reached which span 235 disease states, demonstrating the clinical utility of Optos technology.
Optos, Plc, the leading retinal imaging company, today announces, it is expanding the optomap® ultra-widefield (UWF™) retinal imaging modalities available with the California FA device
Leading Scottish eye imaging company Optos reports significant growth with 22,000 devices installed globally – just in time for its 30th anniversary
You are now leaving the Global site.